ACT001 Suppresses the Malignant Progression of Small‐Cell Lung Cancer by Inhibiting Lactate Production and Promoting Anti‐Tumor Immunity
ABSTRACT Background Improving the “cold” tumor immune microenvironment (TIME) of small‐cell lung cancer (SCLC) represents a promising therapeutic approach. The metabolite lactate plays a crucial role in shaping the immune‐cold tumor microenvironment (TME) and facilitating tumor progression. Phosphog...
Saved in:
| Main Authors: | Xiao‐Jing Ding, Ting Mei, Xiao‐Nan Xi, Jing‐Ya Wang, Wen‐Jing Wang, Yue Chen, Ya‐Xin Lu, Ting‐Ting Qin, Ding‐Zhi Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Thoracic Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/1759-7714.70028 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting PGK1 as a Novel strategy to regulate the sensitivity of HER2 positive gastric cancer to lapatinib
by: Xiaochen Ni, et al.
Published: (2025-07-01) -
Integrative transcriptomic and metabolomic analysis explores the mechanisms by which ACT001 treats MAFLD in mice
by: Jing Liu, et al.
Published: (2025-04-01) -
Metabolic interplay between endometrial cancer and tumor-associated macrophages: lactate-induced M2 polarization enhances tumor progression
by: Xiaodie Liu, et al.
Published: (2025-08-01) -
ACT001 improves OVX-induced osteoporosis by suppressing the NF-κB/NLRP3 signaling pathway
by: Yuan Li, et al.
Published: (2025-04-01) -
ALDOC and PGK1 coordinately induce glucose metabolism reprogramming and promote development of colorectal cancer
by: Liyong Huang, et al.
Published: (2025-06-01)